Apolipoprotein B

Physiological Role

Apolipoprotein B is the obligatory structural protein of all atherogenic lipoproteins (cholesterol-carrying particles capable of depositing in arterial walls). LDL, VLDL, IDL and Lp(a) each carry a single ApoB molecule. This biological property makes ApoB measurement a direct count of the total number of circulating particles.

Cholesterol transport in the blood relies on these lipoproteins. Each atherogenic particle contains a core of cholesterol and triglycerides, wrapped in a phospholipid layer and stabilized by one ApoB molecule. Particle size and density vary: some are large and cholesterol-rich, others small and dense. Each carries exactly one ApoB.

When an LDL particle penetrates the arterial wall, the particle itself initiates the atherogenic process. Its retention in the intima (the inner arterial layer), followed by oxidation, triggers a local response. The more particles circulating, the higher the probability of retention. This is why particle count, measured by ApoB, is more informative than the amount of cholesterol they carry.

Reference Ranges

Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.

Biological Significance

An ApoB level in the optimal zone indicates a low number of circulating atherogenic particles. This profile is associated with low cumulative arterial wall exposure over the years.

Elevated values signal atherogenic particle traffic above the optimal target. This situation can coexist with LDL cholesterol considered normal. This discordance phenomenon frequently occurs in metabolic profiles marked by insulin resistance, where LDL particles are small, dense and numerous.

Very high values reflect a significant particle load. Cumulative exposure over time is the determining factor: Mendelian randomization data show that duration of exposure matters as much as instantaneous concentration.

ApoB gains informative value with repeated measurements. A single value indicates a snapshot. Two or three measurements spaced three to six months apart reveal a trajectory. This trajectory allows evaluation of lipid profile evolution and the effectiveness of nutritional adjustments.

Influencing Factors

Diet. Dietary fat quality directly influences ApoB particle count. High intake of saturated fats and dietary cholesterol tends to increase concentration. Soluble fibres and phytosterols lower the fraction of dietary cholesterol absorbed by the intestine.

Physical activity. Regular exercise, particularly moderate to vigorous aerobic activity, is associated with improved lipid profile. The effect operates through better insulin sensitivity and reduced small, dense LDL particle count.

Body composition. Visceral adiposity (fat surrounding abdominal organs) is a major factor in ApoB elevation. The accompanying insulin resistance promotes hepatic VLDL production, increasing the total number of atherogenic particles.

Insulin sensitivity. Insulin resistance is the primary driver of discordance between LDL cholesterol and ApoB. It causes overproduction of small, dense LDL particles, each carrying one ApoB molecule.

Genetics. Certain genetic variants influence ApoB concentration. Familial hypercholesterolemia, linked to LDL receptor mutations, manifests as elevated ApoB from childhood.

Age and sex. ApoB tends to increase with age. Before menopause, women show lower average values than men. This gap narrows after menopause.

In the Singular Formula

ApoB is one of the lipid markers Singular integrates into the biological profile. No formulation engine rule adjusts a dosage in response to this marker. It reflects the number of circulating atherogenic particles, data central to reading the cardiovascular component.

When ApoB falls in the high or very high zone, the formulation engine activates a rule dedicated to cardiovascular support. This rule adjusts no dosage: it delivers dietary guidance content.

The lever Singular delivers on this marker is dietary. The guidance covers soluble fibre, phytosterols, the Mediterranean pattern and the share of saturated fats. No bioactive in the formula is conditioned by ApoB.

ApoB is measured with triglycerides and HDL cholesterol in the same lipid panel. Triglycerides and ApoB share common metabolic ground: hepatic VLDL overproduction increases the number of atherogenic particles. Each of these three markers opens its own rule, independently of the other two.

Scientific Studies

Frequently Asked Questions